Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Inhibitors

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search
Image of 2D Structure
Search for synonyms (with exact matching search term)

Search term:

Results 1 - 10 of 416 > >>
download as CSV
download all results as CSV
EC Number Inhibitors Commentary Structure
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-([trans-4-[(6-amino-9H-purin-9-yl)methyl]cyclohexyl]methyl)-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 99% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-[(2E)-4-(6-amino-9H-purin-9-yl)but-2-en-1-yl]-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 72% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-[(2Z)-4-(6-amino-9H-purin-9-yl)but-2-en-1-yl]-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 86% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-[4-(6-amino-9H-purin-9-yl)but-2-yn-1-yl]-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 61% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-[4-(6-amino-9H-purin-9-yl)butyl]-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 78% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-[4-[(6-amino-9H-purin-9-yl)methyl]benzyl]-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 98% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(17beta)-N-[6-(6-amino-9H-purin-9-yl)hexyl]-3-oxoandrost-4-ene-17-carboxamide daunorubicin accumulation is 111% of the accumulation in presence of 0.01 mM progesterone Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(1beta,1'beta)-5-bromo-6,6',7,12-tetramethoxy-2-methylberbaman is an effectively and potential agent in reversing Pgp-mediated multidrug resistance by inhibiting the transport function and expression of Pgp Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(1E)-1,5-bis[3,5-bis(methoxymethoxy)phenyl]-4,4-dibromopent-1-en-3-one 58.7% inhibition at 0.01 mM Go to the Ligand Summary Page
Display the word mapDisplay the reaction diagram Show all sequences 7.6.2.2(1E)-1,5-bis[3,5-bis(methoxymethoxy)phenyl]-4,4-dichloropent-1-en-3-one 51.5% inhibition at 0.01 mM Go to the Ligand Summary Page
Results 1 - 10 of 416 > >>
download as CSV
download all results as CSV